4//SEC Filing
Jacobs John C 4
Accession 0001209191-24-002239
CIK 0001000694other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:00 PM ET
Size
8.8 KB
Accession
0001209191-24-002239
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Jacobs John C
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-01-23+83,197→ 83,197 total - Tax Payment
Common Stock
2024-01-23$4.26/sh−40,093$170,796→ 43,104 total - Exercise/Conversion
Restricted Stock Units
2024-01-23−83,197→ 166,393 total→ Common Stock (83,197 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F2]The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the January 23, 2023 grant date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001820836
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 5:00 PM ET
- Size
- 8.8 KB